Weiss Multi-Strategy Advisers’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-29,996
| Closed | -$331K | – | 667 |
|
|
2022
Q2 | $331K | Sell |
29,996
-25,004
| -45% | -$276K | 0.01% | 561 |
|
|
2022
Q1 | $916K | Sell |
55,000
-14,861
| -21% | -$248K | 0.02% | 492 |
|
|
2021
Q4 | $1.33M | Sell |
69,861
-5,139
| -7% | -$98.1K | 0.03% | 429 |
|
|
2021
Q3 | $1.85M | Buy |
75,000
+9,065
| +14% | +$224K | 0.04% | 411 |
|
|
2021
Q2 | $1.72M | Buy |
65,935
+34,874
| +112% | +$908K | 0.04% | 409 |
|
|
2021
Q1 | $983K | Buy |
31,061
+11,936
| +62% | +$378K | 0.02% | 461 |
|
|
2020
Q4 | $887K | Sell |
19,125
-21,426
| -53% | -$994K | 0.02% | 465 |
|
|
2020
Q3 | $1.34M | Buy |
40,551
+1,465
| +4% | +$48.2K | 0.04% | 381 |
|
|
2020
Q2 | $1.07M | Buy |
39,086
+10,086
| +35% | +$277K | 0.03% | 380 |
|
|
2020
Q1 | $868K | Sell |
29,000
-2,000
| -6% | -$59.9K | 0.03% | 301 |
|
|
2019
Q4 | $858K | Buy |
31,000
+11,500
| +59% | +$318K | 0.01% | 430 |
|
|
2019
Q3 | $355K | Buy |
+19,500
| New | +$355K | 0.01% | 410 |
|